At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...
New research provides valuable insights into the brain-body immune connection identifying key communication hubs in the dural sinuses and skull bone marrow at the back of the head.
The research that was published in the journal Brain, used neuroimaging techniques to establish that the dural sinuses, a region at the back of the head that drains deoxygenated blood from the brain, ...
The dural sinuses and skull bone marrow serve as key communication hubs between the brain's central immune system and the body's peripheral immune system.